<DOC>
	<DOCNO>NCT02947087</DOCNO>
	<brief_summary>Primary objective : To describe compare safety efficacy treatment AAT chronic pancreatitis patient undergo total pancreatectomy islet autotransplantation ( TP-IAT ) .</brief_summary>
	<brief_title>Alpha-1 Antitrypsin ( AAT ) Enhances Islet Autograft Survival Patients With Chronic Pancreatitis</brief_title>
	<detailed_description>The goal study ass whether infusion Prolastin-C peri-transplant period enhance islet autograft survival function chronic pancreatitis patient total pancreatectomy islet autotransplantation . This prospective , control , double-blind study . The primary endpoint area curve serum C-peptide level first 4 hour mixed meal tolerance test ( MMTT ) , normalized number islet equivalent ( IEQ ) /kg day 365Â±14 transplant .</detailed_description>
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Pancreatitis , Chronic</mesh_term>
	<mesh_term>Alpha 1-Antitrypsin</mesh_term>
	<mesh_term>Protein C Inhibitor</mesh_term>
	<criteria>Patients schedule total pancreactectomy islet autotransplantation Age &gt; 18 year Diabetes free surgery Patients immunosuppression Patients puestow frey pancreatic surgery Patients Immunoglobulin A ( IgA ) deficiency , know antibody IgA , individual history severe immediate hypersensitivity reaction , include anaphylaxis Alpha1proteinase inhibitor product ( allergic AAT )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Islet autotransplantation</keyword>
	<keyword>Alpha1 anti trypsin</keyword>
</DOC>